| BSN Rank:
179 / 2941
(What's this?) |
|
Accomplish Score: 1447
|
|
Popularity Score: Unavailable
|
|
# in My Circle: 0
|
|
# in My Org(s): 973
|
| We'll Post Your CV for Free! |
| |
| |
|
Speaking/Presenting-Abstract/Poster at Mtg: 44 (572 / 0)
|
|
| |
|
Honors and Awards: 4 (40 / 0)
|
-
Employee MD of the Year - Hematology/Oncology (2003)
-
Letter of Appreciation - Streamlining Guidelines of PSA-Based Practice in Nationwide Veteran Population (2003)
-
Selected Attendee (2003)
|
| |
|
Clinical Trial Activity: 0 (0 / 0)
|
|
| |
|
Grant Support: 68 (612 / 0)
|
-
A Multinational Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Oral MDV3100 in Chemotherapy-Naïve Patients with Progressive Metastatic Prostate Cancer Who Have Failed Androgen Deprivation Therapy. (2011 - 2012)
-
Pilot Study of CS-1008 in Combination with FOLFIRI in Subjects with Metastatic Colorectal Cancer Who Have Failed First-Line Treatment. (2010 - 2012)
-
A Double-Blind, Randomized, Placebo-Controlled Phase III Study to Assess the Efficacy of Recmage-A3 + AS15 ASCI as Adjuvant Therapy in Patients with MAGE-A3 Positive Resected Stage III Melanoma (2010 - 2012)
|
| |
|
Patents Pending: 0 (0 / 0)
|
|
| |
|
Journal - Editor/Reviewer: 0 (0 / 0)
|
|
| |
|
Peer Reviewed Papers, Books, Chapters: 34 (204 / 0)
|
-
Thrombin expression in prostate: a novel finding (2011)
-
Novel Molecular Targets of Azadirachta indica Associated with Inhibition of Tumor Growth in Prostate Cancer (2011)
-
Clinical hypothyroidism in a renal cell carcinoma patient treated with sorafenib (2011)
|
| |
|
Pre/Non Reviewed Papers, Proceedings: 0 (0 / 0)
|
|
| |
|
Membership in Professional Societies: 6 (18 / 0)
|
-
Department of Education Services
College of Medicine, Mayo Clinic
(2009)
-
National Bone Marrow Donor Society (2009)
-
University of Rochester Medical Center (2009)
|
| |
|
White Papers: 0 (0 / 0)
|
|
| |
| Registered on BiotechScienceNews: 1 |
How We Rank
